SCM
Silverarc Capital Management Portfolio holdings
AUM
$489M
This Quarter Return
+2.21%
1 Year Return
+71.55%
3 Year Return
+1,109.63%
5 Year Return
–
10 Year Return
–
AUM
$223M
AUM Growth
-$67.9M
(-23%)
Cap. Flow
-$41.8M
Cap. Flow
% of AUM
-18.79%
Top 10 Holdings %
Top 10 Hldgs %
38.27%
Holding
101
New
18
Increased
23
Reduced
24
Closed
32
Top Buys
| 1 |
Merus
MRUS
|
$7.25M |
| 2 |
89bio
ETNB
|
$6.67M |
| 3 |
Viking Therapeutics
VKTX
|
$6.33M |
| 4 |
Karyopharm Therapeutics
KPTI
|
$6M |
| 5 |
KalVista Pharmaceuticals
KALV
|
$5.69M |
Top Sells
| 1 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$10.6M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
$9.67M |
| 3 |
Immunovant
IMVT
|
$9.22M |
| 4 |
Xenon Pharmaceuticals
XENE
|
$5.62M |
| 5 |
BLU
BELLUS Health Inc.
BLU
|
$5.09M |
Sector Composition
| 1 | Healthcare | 95.65% |
| 2 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Evogene
EVGN
$10.9M
| – | – |
-15,036
| Closed | -$105K |
|